OTLK OUTLOOK THERAPEUTICS INC
P/E
--
Forward P/E
2.85
Price/Sales
753.77
Beta
0.983
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Ascendiant's $10 Target on a Sub-Dollar Stock: Is Outlook Therapeutics a Regulatory Lottery Ticket or a Real Turnaround?
Shares of Outlook Therapeutics surged 8.1% to $0.96 on June 11 after Ascendiant Capital analyst Edward Woo raised his price target from $6 to $10 — implying...
🟢 OUTLOOK THERAPEUTICS INC is trading 12.9% up today after Ascendiant Capital raised its price target to $10
OUTLOOK THERAPEUTICS INC is trading 12.9% up at $1.00 after Ascendiant Capital reiterated its Buy rating and significantly raised its price target. -...
🟢 OUTLOOK THERAPEUTICS INC is trading 8.1% up today after Ascendiant Capital raised its price target to $10
OUTLOOK THERAPEUTICS INC is trading 8.1% up at $0.96 today after Ascendiant Capital reiterated its Buy rating and raised its price target to $10.00. • The new...